Maqola

Placebo-Controlled Dose-Ranging Phase 2 Study of Subcutaneously Administered LHRH Antagonist Cetrorelix in Patients with Symptomatic Benign Prostatic Hyperplasia

F.M.J. DebruyneDepartment of Urology, Academic Hospital Nijmegen, Geert Grooteplein Zuid 16, 426 Afdeling Urologie, 6500 Nijmegen, The Netherlands. [email protected]A A GresD. ArustamovCenter of Urology, Ministry of Health of Republic of Uzbekistan, 700 109 Tashkent, Uzbekistan

European Urologyjournal2008en

ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

Urinary Bladder and Prostate Research Sexual function and dysfunction studies Prostate Cancer Diagnosis and Treatment

Identifikatorlar

DOI: 10.1016/j.eururo.2008.03.069

Iqtiboslar va manbalar

1 ta iqtibos 33 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar